Lariviere Y, Matuvanga TZ, Osang'ir BI, Milolo S, et al. Ad26.ZEBOV, MVA-BN-Filo Ebola virus disease vaccine regimen plus Ad26.ZEBOV booster at 1 year versus 2 years in health-care and front-line workers in the Democratic Republic of the Congo: secondary and exploratory outcomes of an open-label, randomised Lancet Infect Dis 2024 Mar 26:S1473-3099(24)00058.
PMID: 38552653